Skip navigation

Calls to Action

Jacqueline Crawley

PACT Takes First Steps in Answering the Urgent Call for Effective Autism Treatments by Building a Preclinical Testing Platform

Veteran autism researchers partner in an effort to facilitate the discovery of effective treatments for individuals with autism

October 02, 2013

NEW YORK, N.Y. (October 3, 2013) – Autism Speaks, the world’s leading autism science and advocacy organization, today announced the launch of the Preclinical Autism Consortium for Therapeutics (PACT).

Latest Funding Supports Advances in Environmental Science and Innovative Small Business Projects as well as Basic & Clinical Research

Autism Speaks today announced the award of $4.8 million in funding for 14 new research projects. To date, Autism Speaks has committed m

January 07, 2013

New York, N.Y. (January 7, 2013) – Autism Speaks, the world’s leading autism science and advocacy organization, today announced the award of $4.8 million in funding for 14 new research projects. To date, Autism Speaks has committed more than $195 million for research projects that advance understanding of the causes, prevention treatment and cure of autism spectrum disorders (ASD).  

January 03, 2013

Autism Speaks is pleased to announce $4.8 million in funding for 14 new research projects. They include two environmental science grants, two innovative small business grants, six basic and clinical research projects and four targeted research awards.

April 25, 2012

A compound that inhibits the brain chemical glutamate reduced repetitive behaviors and partially improved sociability in mouse models of autism. Though preliminary, the findings represent an important advance in autism research because they are the first to show consistent benefits from a pharmaceutical agent across two core symptoms.